Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building
₹ 700
₹ 274
54
₹ 14,796.00
MumbaiNSE
16-Dec-2021
20-Dec-2021
28-Dec-2021
1 Week | -1.04 |
1 Month | 5.90 |
3 Month | 15.70 |
6 Month | 84.78 |
1 Year | 168.36 |
Initial public offering of 25,547,445* equity shares of face value of Rs. 2 each (Equity Shares) of Supriya Lifescience Limited (The Company or the Issuer) for cash at a price of Rs. 274 per equity share (Offer Price) aggregating to Rs. 700.00 crores, comprising a fresh issue of 7,299,270* equity shares aggregating to Rs. 200.00 crores (Fresh Issue) and an offer for sale of 18,248,175* equity shares aggregating to Rs. 500.00 crores by Satish Waman Wagh (The Promoter Selling Shareholder) (The Offer for Sale, together with the fresh issue, the Offer). The offer will constitute 31.74% of the post-offer paid-up equity share capital.*Subject to finalisation of basis of allotmentThe face value of each equity share is Rs. 2 each. The offer price is 137 times the face value of the equity shares.Bids can be made for a minimum of 54 equity shares and in multiples of 54 equity shares thereafter.
Funding Capital Expenditure Requirements of the Company. Repayment and/or Pre-Payment, in full or part, of certain Borrowings availed by the Company. General Corporate Purposes.
Supriya Lifescience Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - cs@supriyalifescience.com
Website - www.supriyalifescience.com